Agenus Inc (NAS:AGEN)
$ 14.56 0.99 (7.3%) Market Cap: 305.75 Mil Enterprise Value: 341.77 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 54/100

Agenus Inc Business Update Call Transcript

Oct 22, 2021 / 12:30PM GMT
Release Date Price: $78.7 (-21.83%)
Operator

Good day, and thank you for standing by. Welcome to the Agenus business update. (Operator Instructions) I would now like to hand the conference over to your speaker today, Divya Vasudevan, Senior Director of Oncology Strategy and Investor Relations. Please go ahead.

Divya Vasudevan
Agenus Inc. - Senior Director of Oncology Strategy & IR

Thank you very much, Catherine, and thank you all for joining us today. Today's call is being webcast and will be available on our website for replay.

Before we begin, we would like to remind you that this call will include forward-looking statements including statements regarding our clinical development, regulatory and commercial plans and time lines as well as time lines for data release and partnership opportunities. These statements are subject to risks and uncertainties, and we refer you to our SEC filings for more details on these risks.

As a reminder, this call is also being recorded for audio broadcast.

Joining me this morning are Dr. Garo Armen, Chairman and Chief Executive Officer

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot